The latest from DTC Perspectives

Do Consumers Pay Attention to Risk Information in DTC Ads?

Wednesday, 02 December 2009, 03:13 PM

A new study from ORC Guideline found that 41% of consumers pay little to no attention to risk information in DTC TV spots. Print advertisements fair a little better in terms of risk presentation, with 50% of consumers claiming that they pay attention to risk information in print ads, according to the survey.

In terms of online advertising, the study reveals that consumers would rather see risk information disclosed via direct links to independent Web sites (32%) or via a condensed version of risk disclosures available a click away (27%).  Only 26% would prefer to see risk information disclosed via a pharmaceutical company or brand Web site.  Most surprisingly, only 25% would prefer to see risk information displayed via government Web sites.

The results of this study may have implications for how regulatory officials at FDA ask for presentation of risk information in the future. 

The study, by ORC Guidelines, a global market research firm, surveyed a sample of 1,045 adults between October 29-30, 2009.  This study is part of their continuing "Under the Skin" series, surveying consumer's perceptions of the American healthcare system.

Related articles

Saatchi & Saatchi Wins Big at First Ever CLIO Healthcare Awards

Saatchi & Saatchi took home the top prize for their "Silence Your Rooster" campaign for Sanofi-Aventis sleep drug Ambien CR at the first ever CLIO Healthcare Awards

Declines Predicted for Advertising Industry

TNS Media Intelligence is forecasting a decrease in overall advertising spending for the fourth quarter of 2009. The first three quarters of 2009 showed a decline of

Study: Risk Information Insufficient in Online Coupon Offers for Rx Samples

A new study published in The Archives of Internal Medicine reveals that risk information presented in online coupon offers for brand-name prescription drugs is

Study Finds DTC Harmful to the American Public, Offers Recommendations

A recent study in the American Journal of Public Health weighs the opinions for and against DTC and uses these differing opinions to proffer several guidelines to aid

New Harvard Study Reveals DTC Increases Drug Cost to Medicaid

The study, examining the drug clopidogrel’s (Plavix) expenditure and sales before and after its use of DTC reveals that Medicaid expenditures increased while the

Read all related articles

DTC and You

Contact DTC Perspectives, Inc.
 (973)377-2016 (p) (973)377-1106 (f)

Mark Your Calendar Now for the MDPA 

Marketing Disease Prevention in America. (MDPA)
October 19-21, 2010, Atlanta Georgia

 FREE Subscription to our Magazine
Start a free subscription now to the industry's leading
publication focused soley on DTC marketing,
 DTC Perspectives Magazine is published quarterly.

Subscribe to Bob Ehrlich’s newsletter

A weekly blog column from DTCPI CEO Bob Ehrlich
that reflects his observations on key trends affecting
our industry.

     Visit us on Facebook
DTC Perspectives, Inc is now on Facebook. Stay
Informed on the latest trends in the industry.


ABOUT SSL CERTIFICATES